Clinical Trial Update: Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS [NA]

View source ↗

Summary

A clinical trial evaluating whole genome sequencing (ChromoSeq) as an adjunct to conventional genomic profiling in myelodysplastic syndromes, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Washington University School of Medicine | Conditions: Whole Genome Sequencing, Myelodysplastic Syndromes | NA | Status: RECRUITING